Are we making headway against neurofibromatosis?
Interview: Kent Robertson, M.D., Ph.D., associate director of pediatric stem cell transplantation, assistant professor, Department of Pediatrics, Indiana University School of Medicine.
Kent Robertson, M.D., conducted a ground breaking new study that could change the outlook for neurofibromatosis sufferers. Neurofibromatosis is a disease caused by a single genetic mutation that causes life-threatening tumors in children. The tumors are slow growing, unresponsive to chemotherapy and radiation, and almost always grow close to vital organs. In a study conducted by Dr. Robertson, 23 patients received the drug Gleevec. After six months of treatment five patients had one or more tumors reduce in size. Although the study conducted was small, Dr. Roberson believes this treatment will eventually bring relief to those suffering from neurofibromatosis.